Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin

Anti-Cancer Drugs

Volumn 11, Issue 8, 2000, Pages 639-643

  Peters, U ^a   Preisler Adams, S ^a   Hebeisen, A ^a   Hahn, M ^a   Seifert, E ^a   Lanvers, C ^a   Heinecke, A ^a   Horst, J ^a   Jurgens H ^a   Lamprecht Dinnesen, A ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cisplatin; Glutathione S transferase; Ototoxicity; Polymorphism

Indexed keywords

CISPLATIN; GLUTATHIONE TRANSFERASE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; DNA POLYMORPHISM; FEMALE; GENE INDUCTION; HEARING IMPAIRMENT; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIGENE FAMILY; OTOTOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALLELES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CISPLATIN; COCHLEA; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HEARING LOSS, FUNCTIONAL; HUMANS; MALE; OSTEOSARCOMA; OXIDATIVE STRESS; POLYMORPHISM, GENETIC;

EID: 0033790607     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200009000-00007     Document Type: Article

References (24)

1. The ototoxic mechanism of cisplatin
2. Ototoxicity in children with malignant brain tumors treated with the '8 in 1' chemotherapy protocol
3. Development of cis-platinum induced hearing loss in guinea pigs
4. Ototoxicity of chemotherapeutic agents
5. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue
6. Diet is a risk factor in cisplatin ototoxicity
7. Interaction of cisplatin and noise on the peripheral auditory system
8. Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer
9. Cisplatin-induced hearing loss: Influence of the mode of drug administration in the guinea pig
10. Oxidative stress-induced apoptosis of cochlear sensory cells: Otoprotective stratrgies
11. Metabolic polymorphisms and cancer susceptibility
12. Role of glutathione S-transferase isoenzymes in cisplatin-induced nephrotoxicity in the rat
13. Glutathione S-transferase-π expression and glutathione concentration in ovarian carcinoma before and after chemotherapy
14. Immunohistochemical expression of glutathione S-transferase-π can predict chemotherapy response in patients with nonsmall cell lung carcinoma
15. Transfection of glutathione S-transferase (GST)-π antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, and etoposide
16. Co-variation of glutatione transferase expression and cytostatic drug resistance in HeLa cells: Establishment of class Mu glutathione transferase M3-3 as the dominating isoenzyme
17. Glutathione S-transferases in the organ of corti of the rat: Enzymatic activity, subunit composition and immunohistochemical localization
18. Human glutathione S-transferase Theta (GSTT1): cDNA cloning and characterization of a genetic polymorphism
19. Parkinson's disease, pesticides, and glutathione transferase polymorphisms
20. Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: Evidence for linkage with GSTM1A
21. Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 A/B and GSTM1 null polymorphisms at the glutathione S-transferase, GSTM1 locus
22. Influence of polymorphisms at glutathione S-transferase gene loci on allelic losses in head and neck squamous cell carcinomas
23. Polymorphism at the glutathione S-transferase locus GSTM3: Interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma
24. Glutathione S-transferase polymorphisms in MS